Orion Corporation Company Profile

14:13 EST 20th November 2017 | BioPortfolio

Orion Corporation is a Finnish listed company, which develops, manufactures and markets pharmaceuticals, active pharmaceutical ingredients and diagnostic tests for global markets.

The company has a long common history with the former Orion which was established in 1917 and dissolved in a demerger on 1 July 2006.


Orion’s clientele consist of healthcare service providers and professionals like doctors, pharmacies, hospitals, healthcare centers, clinics and laboratories.

Pharmaceutical business

Pharmaceuticals generate about 95% of Orion’s net sales, of which a considerable part comes from proprietary patented pharmaceutical innovations.

Orion has launched already seven new chemical entities to the market, and carries intensive research with a goal to introduce additional new treatments into global markets.

The core therapy areas in Orion’s product and research strategy are

central nervous system
cardiology and critical care
< hormonal and urological therapies.
< In global marketing, Orion collaborates in partnerships with other

pharmaceutical companies.


Orionintie 1A,


Phone: +358 10 4261
Fax: 358 10 426 3815

News Articles [115 Associated News Articles listed on BioPortfolio]

Orion Corporation: Managers' transactions - Hilpi Rautelin

ORION CORPORATION      MANAGERS' TRANSACTIONS 1st of November 2017 at 22.15 EET              Orion Corporation: Managers' transactions - Hilpi Rautelin Orion Cor...

Orion Corporation: Licenses and Growth for Mid-size Companies in Europe

In this episode of PharmaTelevision News Review, Fintan Walton talks with Jukka Muhonen at Orion Corporation. Filmed at Bio-Europe Spring 2010 in Barcelona, Spain, they discuss: • Orion's origins a...

Publishing Of Orion Corporation's Interim Report For January-September 2017 On 26 October 2017

ORION CORPORATION PRESS RELEASE 12 OCTOBER 2017 at 10.30 A.M. EEST Publishing of Orion Corporation's Interim Report for January-September 2017 on 26 October 2017 Orion will publish its ...


34,01 EUR (1 Puja)Fecha de finalización: domingo nov-12-2017 19:39:11 CETPujar ahora | Añadir a lista de seguimiento Biotech365 : STEREO MICROSCOPE ORION S420 BioMarketplace You want to propose...

Professor Heikki Joensuu has been appointed Vice President of Therapy area Oncology, R&D in Orion Corporation

ORION CORPORATION         PRESS RELEASE 7 NOVEMBER 2017 at 8.30 EET                   Professor Heikki Joensuu has been appointed Vice President of Thera...

Orion cortical visual prosthesis system gets FDA expedited access pathway designation

The FDA has granted expedited access pathway designation to Second Sight Medical Products for its Orion cortical visual prosthesis system, according to a company press release.The designation, given t...

CombiMatrix Corporation Reminds Shareholders to Vote "FOR" the Merger With Invitae Corporation

IRVINE, Calif., Nov. 02, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based r...

CombiMatrix Corporation Stockholders Approve Merger Agreement With Invitae Corporation

IRVINE, Calif., Nov. 10, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based r...

PubMed Articles [3 Associated PubMed Articles listed on BioPortfolio]

Orion: Detecting regions of the human non-coding genome that are intolerant to variation using population genetics.

There is broad agreement that genetic mutations occurring outside of the protein-coding regions play a key role in human disease. Despite this consensus, we are not yet capable of discerning which por...

Engagement in the Overdose RIsk InfOrmatioN (ORION) e-Health Tool for Opioid Overdose Prevention and Self-Efficacy: A Preliminary Study.

Increasing awareness of, and information about, overdose risk is an appropriate approach in risk reduction. e-Health technology in substance use disorders is an opportunity to support behavioral chang...

Near infrared circularly polarized light triggered enantioselective photo-polymerization using upconversion nanophosphors.

Circularly polarized light (CPL), is considered to be a true chiral entity and has been suggested as an explanation for the introduction of initial chiral biases into key biomolecular building blocks....

Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

Early Feasibility Study of the Orion Visual Cortical Prosthesis System

This is an early feasibility study of a new device, the Orion Visual Cortical Prosthesis System. The device is intended to stimulate the surface of the visual cortex to induce visual perce...

Prospective Registry on User Experience With The Mapping System For Ablation Procedures

This is an observational, prospective, non-randomized, multicenter, post approval study being conducted in the United States, Europe and Asia-Pacific Regions.

EPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac Arteries

The ORION study is being conducted to determine whether the Epic™ Nitinol Stent for primary stenting of iliac atherosclerotic lesions shows acceptable performance at 9 months.

A Study of Inclisiran in Participants With Renal Impairment Compared to Participants With Normal Renal Function (ORION-7)

This study is a Phase I, single-dose, open-label trial to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics of a single dose of inclisiran subcutaneous (SC) in...

ORION Study: A Study of Monthly Subcutaneous Mircera in Predialysis Patients With Chronic Renal Anemia

This single arm study will assess the long term maintenance of hemoglobin levels, safety and tolerability of once monthly subcutaneous Mircera in predialysis patients with chronic renal an...

Companies [191 Associated Companies listed on BioPortfolio]

Orion Research LLC

Orion Research LLC provides investigative research on public companies and was hired by Pershing Square Capital Management, L.P. to gather information on Herbalife and its Nutriti...

Orion Energy Systems, Inc.

Orion is leading the transformation of commercial and industrial buildings with state-of-the-art energy efficient lighting systems and retrofit lighting solutions. Orion manufactu...

Orion Corporation

Orion Corporation is a Finnish listed company, which develops, manufactures and markets pharmaceuticals, active pharmaceutical ingredients and diagnostic tests for global markets. The company has a ...

Orion Health, Inc.

Orion Health™ is the leading Health Information Exchange (HIE) solution provider with expertise in clinical workflow and integration technology for the healthcare sector. Ori...

Orion Therapeutics, LLC

Orion Therapeutics is a Troy, Michigan-based biotech company with a mission to discover, develop and commercialize novel products derived from neutraceutical and food supplement m...

More Information about "Orion Corporation" on BioPortfolio

We have published hundreds of Orion Corporation news stories on BioPortfolio along with dozens of Orion Corporation Clinical Trials and PubMed Articles about Orion Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Orion Corporation Companies in our database. You can also find out about relevant Orion Corporation Drugs and Medications on this site too.

Quick Search

Relevant Topics

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Corporate Database Quicklinks

Searches Linking to this Company Record